vadastuximab talirine April 12, 2017 vadastuximab talirine Trade Name Orphan Indication Acute myeloid leukemia USA Market Approval USA USA Designation Date 2015-11-10 00:00:00 Sponsor Seattle Genetics, Inc.;21823 30th Drive Southeast;Bothell, Washington, 98021
